Caspases Are Activated in a Branched Protease Cascade and Control Distinct Downstream Processes in Fas-induced Apoptosis

Hirata, Hirokazu; Takahashi, Atsushi; Kobayashi, Susumu; Yonehara, Shin; Sawai, Hirofumi; Okazaki, Toshiro; Yamamoto, Kokichi; Sasada, Masataka

doi:10.1084/jem.187.4.587

Article navigation

Article| February 16 1998

Caspases Are Activated in a Branched Protease Cascade and Control Distinct Downstream Processes in Fas-induced Apoptosis

Hirokazu Hirata,

Hirokazu Hirata

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Atsushi Takahashi,

Atsushi Takahashi

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Susumu Kobayashi,

Susumu Kobayashi

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Shin Yonehara,

Shin Yonehara

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Hirofumi Sawai,

Hirofumi Sawai

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Toshiro Okazaki,

Toshiro Okazaki

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Kokichi Yamamoto,

Kokichi Yamamoto

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Masataka Sasada

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Search for other works by this author on:

This Site

PubMed

Google Scholar

Author and Article Information

Hirokazu Hirata

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Atsushi Takahashi

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Susumu Kobayashi

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Shin Yonehara

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Hirofumi Sawai

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Toshiro Okazaki

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Kokichi Yamamoto

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

Masataka Sasada

From the *Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto 606, Japan; the ‡Department of Viral Oncology, Institute for Virus Research, Kyoto University, Kyoto 606, Japan; and the §College of Medical Technology, Kyoto University, Kyoto 606, Japan

¹Abbreviations used in this paper: DAPI, 4′,6-diamidino-2-phenylindole; DFF, DNA fragmentation factor; DISC, death-inducing signaling complex; DMQD-CHO, acetyl-Asp-Met-Gln-Asp-aldehyde; FSC, forward light scatter; ICE, IL-1β converting enzyme; NuMA, nuclear mitotic apparatus protein; PAK, p21-activated kinase; PARP, poly (ADP-ribose) polymerase; PKCδ, protein kinase C δ; PS, phosphatidylserine; PT, permeability transition; VEID-CHO, acetyl-Val-Ileu-Asp-aldehyde; zVAD-fmk, benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone.

We thank Emad S. Alnemri for the generous gift of cDNAs for caspases; Nancy A. Thornberry for providing YV(bio)KD-aomk; Gerald M. Cohen for anti–caspase-7 Ab; Charles H. Yang for anti-NuMA Ab; Alastair Mackay for critical review of the manuscript and creative suggestions; Yuri A. Lazebnik, Scott H. Kaufmann, William C. Earnshaw, Eisuke Nishida, Fumiko Toyoshima, and Katsumi Takada for helpful discussion and thoughtful suggestions; and Akira Komoriya, Kuniko Takano, Akinori Maeda, and Kouhei Yamashita for help in flow cytometric analysis.

A. Takahashi is a Research Resident of the Japanese Foundation of Aging and Health.

Address correspondence to Atsushi Takahashi, The First Division, Department of Internal Medicine, Kyoto University Hospital, 54 Shogoin Kawara-cho, Sakyo-ku, Kyoto 606, Japan. Phone: 81-75-751-4290; Fax: 81-75-751-4221; E-mail: [email protected]

Received: October 09 1997

Revision Received: December 01 1997

Online ISSN: 1540-9538

Print ISSN: 0022-1007

1998

J Exp Med (1998) 187 (4): 587–600.

https://doi.org/10.1084/jem.187.4.587

Two novel synthetic tetrapeptides, VEID-CHO and DMQD-CHO, could selectively inhibit caspase-6 and caspase-3, respectively. We used these inhibitors to dissect the pathway of caspase activation in Fas-stimulated Jurkat cells and identify the roles of each active caspase in apoptotic processes. Affinity labeling techniques revealed a branched protease cascade in which caspase-8 activates caspase-3 and -7, and caspase-3, in turn, activates caspase-6. Both caspase-6 and -3 have major roles in nuclear apoptosis. Caspase-6 cleaves nuclear mitotic apparatus protein (NuMA) and mediates the shrinkage and fragmentation of nuclei. Caspase-3 cleaves NuMA at sites distinct from caspase-6, and mediates DNA fragmentation and chromatin condensation. It is also involved in extranuclear apoptotic events: cleavage of PAK2, formation of apoptotic bodies, and exposure of phosphatidylserine on the cell surface. In contrast, a caspase(s) distinct from caspase-3 or -6 mediates the disruption of mitochondrial membrane potential (permeability transition) and the shrinkage of cytoplasm. These findings demonstrate that caspases are organized in a protease cascade, and that each activated caspase plays a distinct role(s) in the execution of Fas-induced cell death.

1998

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Caspases Are Activated in a Branched Protease Cascade and Control Distinct Downstream Processes in Fas-induced Apoptosis

Sign in

Client Account

Sign in via your Institution

Suggested Content

Email alerts

This Feature Is Available To Subscribers Only